In summary, we conducted an in vitro study to determine ApoA1’s effects on mBECs under a pathologic environmental condition reminiscent of ALS, based on the well-known endothelial degeneration found in an animal disease model and in ALS patients. This evidence concerns the gene APOA1 and glycogen storage disease VI.